1855-36-3

Basic information

• Product Name: 3,4-DIMETHYLSTYRENEOXIDE
• Synonyms: 3,4-DIMETHYLSTYRENEOXIDE;3,4-Xylyloxirane
• CAS NO: 1855-36-3
• Molecular Formula: C₁₀H₁₂O
• Molecular Weight: 148.22
• Mol File: 1855-36-3.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 208.81°C (rough estimate)
• Flash Point: 95.8°C
• Appearance: /
• Density: 0.8884 (rough estimate)
• Vapor Pressure: 0.0541mmHg at 25°C
• Refractive Index: 1.5003 (estimate)
• CAS DataBase Reference: 3,4-DIMETHYLSTYRENEOXIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 3,4-DIMETHYLSTYRENEOXIDE(1855-36-3)
• EPA Substance Registry System: 3,4-DIMETHYLSTYRENEOXIDE(1855-36-3)

Safety Data

• Hazardous Substances Data: 1855-36-3(Hazardous Substances Data)

Usage

InChI:InChI=1/C10H12O/c1-7-3-4-9(5-8(7)2)10-6-11-10/h3-5,10H,6H2,1-2H3

Upstream product

• 5973-71-7 3,4-dimethylbenzaldehyde 
• 2181-42-2 trimethylsulphonium iodide 
• 107-20-0 2-chloroethanal 
• 2181-44-4 trimethylsulfonium methylsulfate 

Downstream Products

• 1095616-31-1 2-(3,4-dimethylphenyl)-2-hydroperoxyethanol 
• 474114-20-0 4-[(2R)-2-({[2-(3,4-dimethylphenyl)-2-hydroxyethyl]amino}methyl)-3,4-dihydro-2H-chromen-6-yl]benzoic acid 
• 20973-32-4 1-(3,4-dimethyl-phenyl)-2-morpholin-4-yl-ethanol 

Relevant articles and documents

2,6-Substituted chroman derivatives useful as beta-3 adrenoreceptor agonists

This invention relates to novel 2,6-substituted chroman derivatives which are useful in the treatment of beta-3 adrenoreceptor-mediated conditions.

Studies on cognitive enhancing agents. II. Antiamnestic and antihypoxic activities of 1-aryl-2-(2-aminoethoxy)ethanols

A series of 2-(2-aminoethoxy)-1-phenylethanols having a variety of N- and phenyl-substitution patterns as well as 5- and 6-membered heteroaryl counterparts of our prototype compound 1 (2-(2-dimethylaminoethoxy)-1- phenylethanol) have been prepared and evaluated for antiamnestic and antihypoxic activities. Compound 3b, the 3-methylphenyl analogue of 1, proved to be significantly more potent than I in reversing electroconvulsive shock- induced amnesia as well as CO2-induced learning-impairment in mice. It exhibited low acute toxicity in mice and afforded a greater brain/serum concentration ratio than 1 after oral administration to rats.